NCT02316392View on ClinicalTrials.gov

Imaging and Understanding BOS in Lung Transplantation

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Bronchiolitis Obliterans Syndrome
Interventions
DRUG

Hyperpolarized Helium-3 MRI

Subjects will inhale Hyperpolarized Helium-3 gas during the MRI. This gas enhances images and the data collected will be used to determine if it can be used to detect BOS earlier than current standard of care.

Trial Locations (1)

45229

Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02316392 - Imaging and Understanding BOS in Lung Transplantation | Biotech Hunter | Biotech Hunter